Combines multi-user virtual reality with psychedelic science and group therapeutic processes for mental health
Anuma develops group-based digital therapeutics combining extended reality (VR) with psychedelic science to treat end-of-life distress and major depressive disorder. Their proprietary VR platform produces peak experiences and psychologically measurable outcomes comparable to moderate-dose psychedelics, validated in peer-reviewed studies. Anuma operates therapeutic centers across the US, UK, and Europe.
Founded: 2019
Founders: Gregory Roufa, Joseph Hardy, David Glowacki
